Analysts at Stifel Nicolaus & Company downgrade Micrus Endovascular (NASDAQ: MEND) from "buy" to "hold."
According to Stifel Nicolaus & Company, the downgrade in the rating is based on valuation.
MEND’s shares closed at $20.99 yesterday. More Analyst Ratings here
Options & Volatility Edge is for those people who want to make money using cost effective options trading strategies. This product is for anyone—novices and experts. If you understand how to enter an options trade, you need Options & Volatility Edge.
The ETF Professor is truly an appropriate moniker, because the Professor spends hours everyday analyzing the charts of dozens of ETFs EVERY DAY.
Winning Stocks tracks and analyzes attractive stocks that are poised to make great returns for the average investor. Investors receive the right information at the right time, which provides them with the possibility for great gains and the potential to beat the market.
In this game, information is everything. You have to know what is happening before the Street begins trading against you utilizing the new information. We will provide you with that edge.
From novice to pro, Chart-Caster delivers over $11,000 per month* in profitable trade setups across all time-frames from which members can evaluate, select, and replicate within their own trading accounts.
1.877.440.ZING (9464)
